BMY
BRISTOL MYERS SQUIBB COPrice
Daily candles with volume. Callouts mark insider and congressional trades, rating changes, 13F stakes, reports, catalysts, court and regulator actions, Reddit spikes and short-interest jumps. Hover one for the details (tap on phones).
- Mar 30 to Mar 30 3 court rulings: 1:24-cv-06924 CenterWell Pharmacy, Inc.v. Celgene…; 1:23-cv-07871 Louisiana Health Service & Indemnity… and 1 more
- Apr 1 ▼ 1 insider sell $1.9M at $61.67
- Aug 17 ▲ A powerful institutional cluster formed in BMY during Q2 2026, with…
- Aug 25 ▼ 1 insider sell $33.8K at $67.50
- Sep 8 Trial readout: Results Pending: Nivolumab (Phase 3), Completed 61d ago
- Sep 9 ▼ 1 insider sell $403.5K at $64.57
- Sep 10 Trial readout: Results Pending: BMS-986165 (Phase 3), Completed 51d ago
- Oct 5 ▼ Leerink Partners downgrades
- Oct 7 ▼ Ro Khanna sold $1,001 - $15,000, last disclosed Nov 9
- Oct 12 Trial readout: Results Pending: BMS-986165 (Phase 3), Completed 83d ago
- Oct 13 ▲ Ro Khanna bought $1,001 - $15,000, last disclosed Nov 9
- Nov 5 ▼ 1 insider sell $240.6K at $63.31
- Nov 16 New catalyst: subscribers see the details Unlock
Signal stack
Where each data set points today.
- InsidersBEARISH
4 insiders sold $2.5M.
- InstitutionsBULLISH
Q2 2026: 52 added (0 new), 32 trimmed or exited.
- AnalystsBULLISH
14 of 34 rate it Buy or better.
- Short sellersSTEADY
Short interest −6.2% to 46.85M shares. 4.2 days to cover, ≈2.3% of shares.
- TrendUPTREND
2% above its 50-day average.
- SocialQUIET
Crowd 50° (neutral) this week from 2 mentions: 0 bullish, 0 bearish. No setup is alerting.
Who's buying
13F· Q2 2026| Fund | Move | Value |
|---|---|---|
| PRICE T ROWE ASSOCIATES INC /MD/ | DOUBLED | $1.8B |
| FMR LLC | ADD | $938.8M |
| Allianz Asset Management GmbH | ADD | $654.8M |
| NORDEA INVESTMENT MANAGEMENT AB | DOUBLED | $462.9M |
| Capital International Investors | TRIM | $340.8M |
| CAISSE DE DEPOT ET PLACEMENT DU QUEBEC | DOUBLED | $243.6M |
| WELLINGTON MANAGEMENT GROUP LLP | TRIM | $225.5M |
| Employees Provident Fund Board | ADD | $209.8M |
Quarterly 13F filings are due 45 days after each quarter ends.
The Street
34 analysts| Date | Firm | Rating |
|---|---|---|
| Oct 30, 2026 | Morgan Stanley MAINTAIN | Underweight |
| Oct 26, 2026 | Piper Sandler MAINTAIN | Overweight |
| Oct 13, 2026 | Wells Fargo MAINTAIN | Equal-Weight |
| Oct 8, 2026 | Cantor Fitzgerald MAINTAIN | Neutral |
| Oct 7, 2026 | Morgan Stanley MAINTAIN | Underweight |
| Oct 5, 2026 | Leerink Partners DOWNGRADE | Market Perform |
Insider ledger
Form 4| Insider | Type | Value |
|---|---|---|
Haller Julia A Director Nov 5, 2026 | SELL | $240.6K |
Lenkowsky Adam EVP, Chief Commercial Officer Nov 3, 2026 | TAX W/H | $237.5K |
Lenkowsky Adam EVP, Chief Commercial Officer Nov 3, 2026 | EXERCISE | 7,522 sh |
BOERNER CHRISTOPHER S. Chief Executive Officer Nov 1, 2026 | TAX W/H | $107.7K |
Shanahan Karin EVP, Chief Supply Chain & Ops Nov 1, 2026 | EXERCISE | 6,281 sh |
BOERNER CHRISTOPHER S. Chief Executive Officer Nov 1, 2026 | OTHER | 406 sh |
BOERNER CHRISTOPHER S. Chief Executive Officer Nov 1, 2026 | EXERCISE | 2,964 sh |
Shanahan Karin EVP, Chief Supply Chain & Ops Nov 1, 2026 | TAX W/H | $200.7K |
Earnings setup
EstimatesRevision history: 🔒 Fresh data, subscribers only
| Period | EPS est. | Range | 30D rev. | Revenue |
|---|---|---|---|---|
| Current Q | 🔒 Fresh data, subscribers only | |||
| Next Q | 🔒 Fresh data, subscribers only | |||
| Current FY | 🔒 Fresh data, subscribers only | |||
| Next FY | 🔒 Fresh data, subscribers only | |||
Short side
FINRA· Oct 30, 2026Washington
SecBot reports
9 filings · 3 bullish · 1 bearish · 5 neutral- NEUTRAL 144Nov 6, 2026
Director Julia A. Haller filed a Form 144 notice of intent to sell 3,800 shares of Bristol Myers…
The filing is a routine advance notice of a small sale by a director. No material impact expected; monitor for any subsequent Form 4 filings to confirm execution.
- NEUTRAL 8-KOct 29, 2026
Bristol Myers Squibb reported Q3 2026 revenue of $13.07B (+7% YoY), above the $12.73B consensus…
The revenue beat and raised full-year revenue guidance confirm strong Growth Portfolio momentum, but the EPS guidance cut due to business development spending tempers the positive read. Watch for…
- NEUTRAL INST-CLUSTEROct 23, 2026
Four asset managers added BMY positions in Q3 2026, with aggregate buying of $18.3M, while one…
The cluster shows breadth (4 buyers) but negative net dollar flow, indicating small funds accumulating while one large holder exits. Monitor upcoming 10-Q for fundamental catalysts that could…
- BEARISH ANALYST-DOWNGRADEOct 5, 2026
Leerink Partners downgrades BMY to Market Perform, PT $59 (down 19%)
All BMY filing & press-release reports (9)
- 144 reportNov 6, 2026
- 8-K reportOct 29, 2026
- INST-CLUSTER reportOct 23, 2026
- Leerink Partners downgrades BMY to Market Perform, PT $59 (down 19%)Oct 5, 2026
- INST-CLUSTER reportAug 17, 2026
- Argus Research upgrades BMY to Buy, PT $75 (+13.8%)Aug 5, 2026
- 8-K reportJul 30, 2026
- COURT-RULING reportFeb 26, 2026
- DEFA14A reportMar 25, 2026